Integrating Real-World Evidence into Treatment Plans for Relapsing MS (Expired) — Enquiring Minds, LLC

Integrating Real-World Evidence into Treatment Plans for Relapsing Multiple Sclerosis (Expired)

Faculty: Robert T. Naismith, MD, MPH and Carrie M. Hersh, DO, MSc Grant Support: Genentech and Sanofi Genzyme

Joint Providers: Postgraduate Institute for Medicine and Enquiring Minds, LLC

Access the Activity Online

Using real-world evidence, tailor treatment plans for 3 patients diagnosed with relapsing multiple sclerosis, each of whom may be experiencing new symptoms, breakthrough disease, disease progression, comorbid conditions, or highly active disease.

Expired

Woman in her 30s smiling outside — Dolly

Dolly is a 32-year-old woman who developed optic neuritis in her right eye. Upon neurologic examination, it is noted that Dolly has 20/30 vision in her right eye, a mild central scotoma with color desaturation, and afferent pupillary defect.

Dolly

Hispanic gentleman standing outside — Mateo

Mateo is a 30-year-old Hispanic gentleman who presented with left-sided optic neuritis in 2015 after having partially recovered following a course of intravenous methylprednisolone (IVMP) at a dose of 1000 mg for 5 days.

Mateo

Woman of color in suit smiling at camera — Joanne

Joanne is a 50-year-old woman who presented last year with transverse myelitis (TM), which manifested as leg weakness, numbness, and pain, as well as loss of balance and urinary symptoms.

Joanne

Rare Diseases and the Non-Physician Provider (Expired)

Assessing the Efficacy of Treatment Plans for Patients with Bipolar Disorder(Expired)